SCHEMBL4601808

SCHEMBL4601808

COc1cc2c(c(OC)c1)CN(Cc1ccc(Cl)cc1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.48
ABCC1 P33527 2/20 0.48
ABCG2 Q9UNQ0 2/20 0.48
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
DRD4 P21917 3/20 0.46
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
DRD2 P14416 1/20 0.45
DRD3 P35462 1/20 0.45
KMT2A Q03164 1/20 0.44
DHCR7 Q9UBM7 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
PAX8 Q06710 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31014028 0.79 ABCB1 (0.49) ABCB1ABCC1ABCG2ALDH1A1SMN1; SMN2
SCHEMBL5239908 0.77 ALDH1A1 (0.52) ABCB1ABCC1ABCG2ALDH1A1LMNA
SCHEMBL10383284 0.76 ABCB1 (0.74) ABCB1ABCC1ABCG2SMN1; SMN2KDM4E
SCHEMBL5243392 0.76 ABCB1 (0.46) ABCB1ABCC1ABCG2ALDH1A1SMN1; SMN2
SCHEMBL30550477 0.75 SIGMAR1 (0.54) ALDH1A1SMN1; SMN2KDM4EDRD4LMNA
SCHEMBL18356020 0.75 SIGMAR1 (0.51) ALDH1A1SMN1; SMN2DRD4DRD3KMT2A
SCHEMBL382900 0.74 ABCB1 (0.64) ABCB1ABCC1ABCG2SMN1; SMN2KDM4E
SCHEMBL1002978 0.74 MEN1 (0.45) ALDH1A1SMN1; SMN2LMNAPOLBMAPK1
SCHEMBL5243101 0.73 ABCB1 (0.44) ABCB1ABCC1ABCG2ALDH1A1SMN1; SMN2
SCHEMBL5245082 0.71 KDM4E (0.40) ALDH1A1SMN1; SMN2KDM4EDRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912940-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2008-04-23 EP disclosed
WO-2007021309-A1 SUBSTITUTED ISOINDOLONES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2007-02-22 WO disclosed